FindTrial
Sign In

Comparison of two combination of drugs (ropivacaine with fentanyl and ropivacaine with clonidine ) to see which provides better pain relief and better anaesthesia in women undergoing cesarean section .

Comparison of clinical efficacy of intrathecal 0.75% isobaric ropivacaine with fentanyl vs clonidine as adjuvants in cesarean section: a prospective randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/01/016903
Enrollment
60
Registered
2019-01-04
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: ROPIVCAINE WITH CLONIDINE: Intrathecal 0.75% Isobaric Ropivacaine (15mg) with 30mcg Clonidine with total volume of 2.5ml Control Intervention1: ROPIVACAINE WITH FENTANYL: Intrathecal 0.

Sponsors

All India Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Pregnant patients with ASA I and II 2)Patients scheduled for elective caesarean section

Exclusion criteria

Exclusion criteria: 1)Patient refusal to participate in the study 2)History of allergy to any of the study drug 3)Multiple gestation 4)Patients in whom spinal anaesthesia is contraindicated (spinal abnormalities, infection at the site of injection, coagulopathies, raised intracranial tension)

Design outcomes

Primary

MeasureTime frame
1.Time to first post operative analgesic requirement (Total duration of analgesia) 2.To assess the onset and total duration of sensory and motor blockadeTimepoint: Intra operative and 6 hours in post operative period—

Secondary

MeasureTime frame
1.To assess the hemodynamic parameters 2.To assess the patient satisfaction level 3.To assess the surgeon satisfaction level 4.To note any adverse effectsTimepoint: Intra operative and 6 hours in post operative period—

Countries

India

Contacts

Public ContactMRUDULA B S

All India Institute of Medical Sciences, New delhi

drdevalina@gmail.com9868397914

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026